| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Eastham Karin is a Director at GERN with holdings across 5 companies. Recent SEC Form 4 filings include 0 buys and 29 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2023 | VCYT Veracyte, Inc. | Director | Sale+OE | 10,000 | $25.00 | $250,001.00 | -29.9% | +4.3% | -3.4% | |
| Sep 13, 2022 | NKTR Nektar Therapeutics | Director | Sell | 21,267 | $3.61 | $76,773.87 | -62.0% | -23.7% | -80.6% | |
| Dec 17, 2021 | VCYT Veracyte, Inc. | Director | Sale+OE | 5,000 | $45.00 | $225,000.00 | -36.4% | -38.7% | -39.1% | |
| Nov 1, 2021 | VCYT Veracyte, Inc. | Director | Sell | 4,400 | $32,978.71 | $145,106,339.40 | -44.7% | -41.3% | -60.1% | |
| Aug 2, 2021 | VCYT Veracyte, Inc. | Director | Sell | 4,400 | $43.91 | $193,193.91 | -29.8% | +17.9% | -39.4% | |
| May 3, 2021 | VCYT Veracyte, Inc. | Director | Sell | 4,427 | $48.27 | $213,699.64 | -13.8% | -4.5% | -53.3% | |
| Feb 25, 2021 | VCYT Veracyte, Inc. | Director | Sale+OE | 6,250 | $60.70 | $379,358.58 | -60.9% | - | - | |
| Jan 2, 2019 | ILMN Illumina, Inc. | Director | Sale+OE | 5,000 | $294.08 | $1,470,381.31 | -3.3% | - | - | |
| May 21, 2018 | ILMN Illumina, Inc. | Director | Sell | 1,000 | $269.80 | $269,802.20 | -2.6% | - | - |